The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial

Biological Trace Element Research

Volumn 172, Issue 1, 2016, Pages 72-78

  Jamilian, Mehri ^a   Bahmani, Fereshteh ^b   Siavashani, Mehrnush Amiri ^c   Mazloomi, Maryam ^d   Asemi, Zatollah ^b   Esmaillzadeh, Ahmad ^e,f,g  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chromium; Endocrine profiles; Inflammation; Polycystic ovary syndrome; Supplementation

Indexed keywords

C REACTIVE PROTEIN; CHROMIUM; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; PLACEBO; BIOLOGICAL MARKER;

ACNE; ADULT; ALOPECIA; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENDOCRINE FUNCTION; FEMALE; HIRSUTISM; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MINERAL SUPPLEMENTATION; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PATIENT COMPLIANCE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; TOTAL ANTIOXIDANT CAPACITY CONCENTRATION; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; ENDOCRINE SYSTEM; POLYCYSTIC OVARY SYNDROME;

BIOMARKERS; CHROMIUM; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENDOCRINE SYSTEM; FEMALE; HIRSUTISM; HUMANS; INFLAMMATION; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME;

EID: 84948680038     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0570-6     Document Type: Article

References (35)

1. Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z (2015) Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 82(6):885–891
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749
3. Hyderali BN, Mala K (2015) Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 191:15–22
4. Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO (2012) Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18(2):112–126
5. Kaya C, Pabuccu R, Berker B, Satiroglu H (2010) Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors. Fertil Steril 93(4):1200–1207
6. Chakraborty P, Ghosh S, Goswami SK, Kabir SN, Chakravarty B, Jana K (2013) Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol Trace Elem Res 152(1):9–15
7. Lucidi RS, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG (2005) Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril 84(6):1755–1757
8. Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8):1124–1131
9. Tian YY, Zhang LY, Dong B, Cao J, Xue JX, Gong LM (2014) Effects of chromium methionine supplementation on growth performance, serum metabolites, endocrine parameters, antioxidant status, and immune traits in growing pigs. Biol Trace Elem Res 162(1–3):134–141
10. Jain SK, Patel P, Rogier K (2006) Trivalent chromium inhibits protein glycosylation and lipid peroxidation in high glucose-treated erythrocytes. Antioxid Redox Signal 8(1–2):238–241
11. Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z (2015) Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res. [Epub ahead of print].
12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25
13. Jamilian M, Asemi Z (2015) Chromium supplementation and the effects on metabolic status in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab 67(1):42–48
14. Amooee S, Parsanezhad ME, Ravanbod Shirazi M, Alborzi S, Samsami A (2013) Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: a double-blind randomized clinical trial. Iran J Reprod Med 11(8):611–618
15. Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140(7):815–830
16. Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L (2000) Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 73(6):1149–1154
17. Olsen EA, Hordinsky MK, Price VH, et al. (2004) Alopecia areata investigational assessment guidelines—part II. National Alopecia Areata Foundation. J Am Acad Dermatol 51(3):440–447
18. Tatsch E, Bochi GV, Pereira Rda S, et al. (2011) A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44(4):348–350
19. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239(1):70–76
20. Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105(5):581–584
21. Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9(6):515–540
22. Lachin JM(2015) Fallacies of last observation carried forward analyses. Clin Trials. [Epub ahead of print].
23. Bargiota A, Diamanti-Kandarakis E (2012) The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab 3(1):27–47
24. Jain SK, Croad JL, Velusamy T, Rains JL, Bull R (2010) Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res 54(9):1371–1380
25. Perricone NV, Bagchi D, Echard B, Preuss HG (2010) Long-term metabolic effects of different doses of niacin-bound chromium on Sprague-Dawley rats. Mol Cell Biochem 338(1–2):91–103
26. Kamei N, Tobe K, Suzuki R, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281(36):26,602–26,614
27. Jialal I, Devaraj S, Venugopal SK (2004) C-reactive protein: risk marker or mediator in atherothrombosis? Hypertens 44(1):6–11
28. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115(5):1111–1119
29. Guha M, Bai W, Nadler JL, Natarajan R (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275(23):17,728–17,739
30. Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Matsuhisa M, Yamasaki Y (2005) Oxidative stress and the JNK pathway in diabetes. Curr Diabetes Rev. 1(1):65–72
31. Sahin N, Akdemir F, Orhan C, et al. (2012) A novel nutritional supplement containing chromium picolinate, phosphatidylserine, docosahexaenoic acid, and boron activates the antioxidant pathway Nrf2/HO-1 and protects the brain against oxidative stress in high-fat-fed rats. Nutr Neurosci 15(5):42–47
32. Dogukan A, Tuzcu M, Juturu V, et al. (2010) Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fat-fed and streptozotocin-treated rats. J Ren Nutr 20(2):112–120
33. Onderci M, Sahin K, Sahin N, Cikim G, Vijaya J, Kucuk O (2005) Effects of dietary combination of chromium and biotin on growth performance, carcass characteristics, and oxidative stress markers in heat-distressed Japanese quail. Biol Trace Elem Res 106(2):165–176
34. Tan GY, Zheng SS, Zhang MH, Feng JH, Xie P, Bi JM (2008) Study of oxidative damage in growing-finishing pigs with continuous excess dietary chromium picolinate intake. Biol Trace Elem Res 126(1–3):129–140
35. Jain SK, Kannan K (2001) Chromium chloride inhibits oxidative stress and TNF-alpha secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem Biophys Res Commun 289(3):687–691